Last reviewed · How we verify
NCT04489030
Magnifying NBI Endoscopy for Gastric Condition
trial testing Magnifying narrow-band imaging endoscopy in Gastritis H Pylori in 254 participants. Completed in 31 August 2020.
30 April 2020
Quick facts
| Lead sponsor | Soonchunhyang University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 254 |
| Start date | 1 June 2016 |
| Primary completion | 30 April 2020 |
| Estimated completion | 31 August 2020 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Magnifying narrow-band imaging endoscopy
Conditions studied
- Gastritis H Pylori — all drugs for Gastritis H Pylori →
Sponsor
Soonchunhyang University Hospital
Who can join
Adults 20 to 70, any sex, with Gastritis H Pylori. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recently, the improved resolution with standard endoscopy allows the close observation of highly inflamed gastric mucosa without a magnifying view. In a previous study, the investigators established the endoscopic classification of H. pylori-infected stomach by non-magnifying standard endoscopy. One normal RAC pattern and three types of abnormal patterns were observed. Overall diagnostic accuracy for predicting H. pylori-infection was 91.6%. However, there is no comparison study predicting H. pylori-infection and precancerous gastric lesions between standard and magnifying endoscopy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Standard <i>vs</i> magnifying narrow-band imaging endoscopy for diagnosis of <i>Helicobacter pylori</i> infection and gastric precancerous conditions.
Cho JH, Jeon SR, Jin SY, Park S. · · 2021 · cited 13× · PMID 34025076 · DOI 10.3748/wjg.v27.i18.2238
Verify or expand the search:
- PubMed search for NCT04489030
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastritis H Pylori
Currently open trials in the same condition.
- NCT07224048 — Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2 · Phase 4 · active not recruiting
Other Soonchunhyang University Hospital trials
Trials by the same sponsor.
- NCT07213596 — Virtual Reality Treatment for Trauma Related to COVID-19 Infection · NA · not yet recruiting
- NCT06950489 — Tegoprazan and Amoxicillin Dual Therapy · recruiting
- NCT06682533 — Tegoprazan- Versus PPI-based H. Pylori Eradication · recruiting
- NCT06684860 — RUT vs. Molecular Testing for H. Pylori · recruiting
- NCT06369896 — Digital Single-operator Cholangioscopy and Intraductal Ultrasound for Nonicteric Biliary Strictures · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04489030 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Soonchunhyang University Hospital
- Last refreshed: 29 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04489030.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing